Clinical Trial Update: Safety and Immunogenicity Study of Human Papilloma Virus Vaccine in Women Aged 9 to 30 and Men Aged 9 to 17 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and immunogenicity of a human papillomavirus vaccine in women aged 9-30 and men aged 9-17; the trial status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: Beijing Chaoyang District Centre for Disease Control and Prevention | Conditions: Cervical Cancer | Phase 1 | Status: UNKNOWN